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Abstract
Background: Biology is moving fast toward the virtuous circle of other disciplines: from data to quantitative
modeling and back to data. Models are usually developed by mathematicians, physicists, and computer scientists
to translate qualitative or semi-quantitative biological knowledge into a quantitative approach. To eliminate
semantic confusion between biology and other disciplines, it is necessary to have a list of the most important and
frequently used concepts coherently defined.
Results: We propose a novel paradigm for generating new concepts for an ontology, starting from model rather
than developing a database. We apply that approach to generate concepts for cell and molecule interaction
starting from an agent based model. This effort provides a solid infrastructure that is useful to overcome the
semantic ambiguities that arise between biologists and mathematicians, physicists, and computer scientists, when
they interact in a multidisciplinary field.
Conclusions: This effort represents the first attempt at linking molecule ontology with cell ontology, in IMGT-
ONTOLOGY, the well established ontology in immunogenetics and immunoinformatics, and a paradigm for life
science biology. With the increasing use of models in biology and medicine, the need to link different levels, from
molecules to cells to tissues and organs, is increasingly important.
Introduction
Biology is a knowledge-based discipline. Many predic-
tions and interpretations of biological data are made by
comparing the data against existing knowledge. Tradi-
tionally, the knowledge base in biology has resided
within the heads of experienced scientists who have
devoted much study and became experts in their parti-
cular domain. This approach worked well in the past,
when considerable effort was needed to tease a few new
data out of biological experiments. However, this situa-
tion is changing rapidly, and biology is moving fast
toward the virtuous circle of other disciplines: from data
to quantitative modeling and back to data. Models are
usually developed by mathematicians, physicists, and
computer scientists to translate qualitative or semi-
quantitative biological knowledge into a quantitative
approach [1].
To eliminate semantic confusion between biology and
other disciplines, it is necessary to have a list of the
most important and frequently used concepts coherently
defined so that involved people could use such a set of
definitions to create new models and software, to pro-
vide an exact, semantic specification of the concepts
used in an existing schema and to curate and annotate
existing database entries consistently. We notice here
that it is important to understand that semantic ambigu-
ities also can arise between human experts. However, in
the course of a conversation usually enough background
knowledge and context is available so that semantic
ambiguities are most often faster resolved than even
consciously recognized. This is possible because of our
intelligent capabilities which computers, programs and
databases, at least for the near future, fall yet short of.
An ontology describes basic concepts in a domain and
defines relations among them. Basic building blocks of
ontology design include concepts and their instances;
properties of each concept describing various features
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and attributes of the concept (slots, sometimes called
roles or properties); restrictions on slots (facets, some-
times called role restrictions). An ontology provides a
common vocabulary for researchers who need to share
information in the domain and allows to build knowl-
edge databases. Ontologies are widely used in biology
and medicine and several important ontology systems
have been established. They contribute to a precise and
exhaustive way to access bio-information and define
concepts in a precise and rigorous way [2-9]. Interest-
ingly, despite or because of the complexity of the
immune response, IMGT-ONTOLOGY, the first ontol-
ogy for immunogenetics and immunoinformatics, is also
conceptually one of the more advanced biological ontol-
ogies [2-6], on which has been built IMGT®, the interna-
tional ImMunoGeneTics information system® http://
www.imgt.org[10].
Other important efforts are underway to link models
at different scales by means of markup languages (i.e.
XML). CellML project is one of this http://www.cellml.
org. The CellML language is an open standard based on
the XML markup language. CellML is being developed
by the Auckland Bioengineering Institute at the Univer-
sity of Auckland and affiliated research groups. The
purpose of CellML is to store and exchange computer-
based mathematical models. CellML allows scientists to
share models even if they are using different modeling
tools. It also enables them to reuse components from
one model in another, thus accelerating model
development.
Whereas usually ontologies led to knowledge data-
bases, in what follows, we adopted another approach in
which concepts for an ontology of cell and molecule
interaction were generated starting from an agent based
model (ABM), the Catania Mouse Model (CMM for
short) and its computer implementation, the SimTriplex
simulator [11,12]. SimTriplex simulates the immune sys-
tem response elicited by the Triplex vaccine [13,14]
against mammary carcinoma. This effort provides a
solid infrastructure that is useful to overcome the
semantic ambiguities that arise between biologists and
mathematicians, physicists, and computer scientists,
when they interact in such a multidisciplinary field.
The development of ontologies for molecular and cel-
lular biology information, and the sharing of those
ontologies within the bioinformatics community, are
central problems in bioinformatics. If the bioinformatics
community is to share ontologies effectively, ontologies
must be exchanged in a form that uses standardized
syntax and semantics. For this reason, while the initial
motivation of our study was to present an ontology for
the CMM, the paradigm we show here has wider appli-
cations as it bridges the molecule ontology with cell
ontology (Figure 1). This is achieved by defining, at the
same time, interactions in terms of cellular and molecu-
lar components of a biological system.
Implementation
The Catania Mouse Model (CMM) has been developed
using Unified Modeling Language (UML) http://www.
uml.org/. UML is a diagramming language or notation
to specify, visualize and document different types of
models and object oriented software systems. UML
helps in visualizing design and in communication. We
used Umbrello UML Modeller http://uml.sourceforge.
net, an open source tool that allows to manage and cre-
ate UML based models. UML was selected because it is
a widely-used system for the representation of objects
and their relationships. Moreover the Umbrello tool was
used to export the CMM classes into Extensible Markup
Language/Resource Description Format (XML/RDF), in
order to create the concepts of CMM-Ontology. XML
was developed by the W3C http://www.w3.org. The cur-
rent standard for the XML Schema Language is con-
trolled by the XML Schema Working Group of the
W3C. XML is a good candidate to share ontologies
because of the significance of the Web and Web-based
applications [15-17]. It is clear that the Web is rapidly
becoming the primary method for the exchange of
information and data, and that XML is currently the
leading candidate for a generic language for the
exchange of semi-structured objects.
Distribution
CMM-Ontology main concepts, with controlled voca-
bularies and rules, are publicly available from the Com-
putational Immunology and Immunomics Group
homepage at http://www.immunomics.eu. Available for-
mats are XML and XMI. The concepts of Identification
for cellular components and the concepts of interaction
have been added in IMGT-ONTOLOGY http://www.
imgt.org.
From the model to the CMM-Ontology main concepts
CMM-Ontology concepts were generated from the
model CMM. They provide a semantic standardization
of the knowledge in the biological modeling field. They
are used to identify the main biological entities used in
the model as well as their interactions. We focus on two
main types of concept: the concepts of identification
and the concepts of interaction. These concepts bridge
the gap between molecular component ontology and
cellular component ontology. It is expected that they
will allow scientists to easily identify the main biological
entities they use, to model any given biological scenario.
Concepts of Identification
Concepts of identification for molecular components
have been analyzed extensively in IMGT-ONTOLOGY
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[3-6]. We therefore focus, in CMM and CMM-Ontol-
ogy, on the identification of the cellular entities involved
in modeling the competition between cancer and the
immune system with or without exogenous stimulation
with a cancer vaccine. In CMM, and in accordance with
UML, the classes have been developed as a “class
diagram” (these classes correspond to concepts in
CMM-Ontology). A class defines the attributes and the
methods of a set of objects. All objects of a given class
(instances of this class) share the same behavior, and
have the same set of attributes (each object has its own
set). In UML, classes are represented by rectangles, with
the name of the class, and can also show the attributes
and operations of the class in two other “compartments”
inside the rectangle. Interfaces are abstract classes,
which means that instances cannot be directly created
inside them. They can contain operations but not attri-
butes. An association represents a relationship between
classes, and gives the common semantics and structure
for many types of “connections” between objects. Asso-
ciations are the mechanism that allows objects to com-
municate with each other. In UML, associations are
represented as lines connecting the classes participating
in the relationship. Aggregations are a special type of
Figure 1 Relations between the Molecule ontology of IMGT-ONTOLOGY that comprises concepts of identification, description and
numerotation [3-6]and the CMM-Ontology that allowed to define concepts of interactions, a novel component of IMGT-ONTOLOGY
(this paper). Whereas the concepts of identification, description and numerotation were defined to manage data in IMGT databases and tools
and therefore immunogenetic knowledge in normal and pathological conditions (cancer, allergy, autoimmune disease...) [6,10], the concepts of
identification were defined from mathematical and statistical models related to vaccination protocol [11,12].
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association in which the two participating classes do not
have an equal status, but make a “whole-part” relation-
ship. An aggregation describes how the class that takes
the role of the whole, is composed of (has) other classes,
which takes the role of the parts. In UML, aggregations
are represented by an association line that ends in a dia-
mond on the side of the whole. A generalization associa-
tion between two classes puts them in a hierarchy
representing the concept of inheritance of a derived
class from a base class. In UML, generalizations are
represented by a line connecting the two classes, with
an ending arrow on the side of the base class. Contain-
ment associations represent an operation implementa-
tion. In UML, containments are represented by a line
with a circle. In CMM-Ontology, the concepts of identi-
fication and their instances, generated from the model,
are the following (Figure 2):
• MolecularComponent. This concept identifies the
molecules. Instances of this concept are: immuno-
globulin (IG), T cell receptor (TR), interleukin (IL),
antigen (Ag), immunocomplex (IC), major
histocompatibility complex (MHC), major histocom-
patibility complex class I (MHC-I), major histocom-
patibility complex class II (MHC-II), peptide/MHC-I
(pMHC-I), peptide/MHC-II (pMHC-II), Fc receptor
(FcR), interleukin receptor (IL-R), interferon (IFN),
complement (Cpt).
• MoleculeActivity. This concept identifies activities
mediated by molecules. Instances of this concept are
binding, recognition, inhibition of proliferation,
killing.
• CellularComponent. This concept identifies the
cells. Instances of this concept are B lymphocyte (B),
T lymphocyte (T), macrophage (M), natural killer
(NK), dendritic cell (DC), cancer cell (CC), vaccine
cell (VC), mast cell (MC).
• CellActivity. This concept identifies the activities
that a cell can carry out. These activities can involve
another cell and/or a molecule. Instances of this
concept are detailed in Figure 2.
• CellActivationStatus. This concept identifies the
activation status of a cell. Instances of this concept
are: naive, primed, activated, resting, anergic.
Figure 2 Concepts of identification in CMM-Ontology. These concepts have been added to IMGT-ONTOLOGY [6] for allowing identification
of the component (MolecularComponent, CellularComponent), component status (CellLifeStatus, CellDifferentiationStatus, CellActivationStatus),
activity (MoleculeActivity, CellActivity) and function (CellFunction). The name of the concepts of identification are shown in bold and the
instances are shown with a prefixed ‘+” sign.
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• CellFunction. This concept identifies the functions
that a cell can perform. Instances of this concept
are: helper (helper 1, helper 2), regulatory, cytotoxic,
antigen presenting cell (APC).
• CellDifferentiationStatus. This concept identifies
the differentiation status of a cell. Instances of this
concept are, for example, memory cell, plasma cell.
• CellLifeStatus. This concept identifies the life sta-
tus of a cell and was specifically included for model-
ing purposes. Instances of this concept are: alive (i.e.
a cell is performing its own job), dead (a cell to be
removed from the system) or dying (a cell starting
an apoptosis process and supposed to do some other
actions before it dies, i.e. releasing of antigens or
some other cell product).
Concepts of interaction
An interaction between two entities is a complex action
which eventually ends in a status change of one or both
entities. In the immune system, interactions can be spe-
cific (adaptive immunity) or non specific (innate immu-
nity). Specific interactions characterize the immune
adaptive response and comprise a specific recognition
phase between two entities, the antigen receptor and an
antigen. These interactions involve the recognition of an
antigen by:
• either an immunoglobulin (IG) specific for that
antigen (in CMM, native p185 antigen). The antigen
can be either soluble or adsorbed at the surface of a
follicular dendritic cell in the lymph node;
• or a T cell receptor (TR) specific for a peptide/
MHC. The peptide (p) resulting from antigen pro-
cessing by a cell is presented at the surface of that
cell in the groove of a MHC protein of class I or II
(MHC-I or MHC-II) [18]. A TR is specific of a
pMHC-I or pMHC-II (in CMM, peptides processed
from p185 and presented by MHC-I or MHC-II).
Immune recognition can be eventually enhanced by
adjuvants.
In CMM, the interactions have been modeled using
component diagrams. They show the components
(either component technologies or sections of the sys-
tem which are clearly distinguishable) and the artifacts
they are made of, such as source code files, or relational
database tables. Components can have interfaces (i.e.
abstract classes with operations) that allow associations
between components.
In CMM-Ontology, the concepts of interaction and
their instances, generated from the model, are the fol-
lowing (Figure 3):
1. The “Molecule_Molecule_Interaction” concept. If
the Molecule is a soluble immunoglobulin (IG) specific
for an antigen, and if the other Molecule encountered is
that antigen (Ag), IG binds to Ag and forms an immu-
nocomplex (that can be captured by a macrophage).
That instance of the “Molecule_Molecule_Interaction”
concept is
• Immunoglobulin_Antigen. In CMM, Ag is the
native p185 antigen (Figure 4).
2. The “Cell_Molecule_Interaction” concept. If the
Cell is a B lymphocyte, a macrophage or a dendritic cell,
and if the Molecule is an antigen, the cell can internalize
the native antigen, process it and present it as peptide
bound to MHC-II (pMHC-II) protein at the cell surface.
The cell becomes a professional antigen presenting cell
(or APC). Three instances can therefore be defined:
• B lymphocyte_Antigen (Figure 5). If, in a lymph
node, a naive B lymphocyte expresses at the cell sur-
face a membrane IG which is specific for the native
antigen (in CMM, p185 antigen), B lymphocyte
internalizes the membrane IG and the bound Ag
and processes the IG-Ag complex into peptides
which are then presented by MHC-II (pMHC-II) at
the B lymphocyte surface. B lymphocyte becomes an
APC.
• Macrophage_Antigen. If a macrophage encounters
a native antigen (in CMM-Ontology, p185 antigen)
or an immunocomplex, the macrophage internalizes
the antigen or the immunocomplex and processes it
into peptides which are then presented by MHC-II
(pMHC-II) at the macrophage cell surface. Macro-
phage becomes an APC.
• Dendritic cell_Antigen. If a naive dendritic cell
encounters a native antigen (in CMM, p185 antigen)
or an immunocomplex, the dendritic cell internalizes
the antigen or the immunocomplex and processes it
into peptides which are then presented by MHC-II
(pMHC-II) at the dendritic cell surface. Dendritic
cell becomes an APC.
3. The “Cell_Cell_Interaction” concept.
(a) If, in a lymph node, one Cell is a T lymphocyte
[helper] (Th) and the other Cell is a B lymphocyte
[APC], the T cell (identified as CD4+) becomes an
activated T helper lymphocyte that helps the B cell
to differentiate into plasma cell or memory cell
(Figure 6) At the molecular level, the T cell receptor
(TR) at the surface of the T lymphocyte [helper]
(Th) binds specifically pMHC-II at the surface of the
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B lymphocyte [APC], Th proliferates and secretes
interleukin 2 (IL2). At the same time, B lymphocyte
proliferates and differentiates into a plasma cell (that
secretes IG) or into a memory cell (with IG at its
surface). That instance of the “Cell_Cell_Interaction”
concept is:
• T lymphocyte [helper]_B lymphocyte [APC]
(Figure 6). Two other instances involving a Th and
an APC are the following:
-T lymphocyte [helper]_Macrophage [APC];
-T lymphocyte [helper]_Dendritic cell [APC].
Following interaction with Macrophage [APC] or
Dendritic cell [APC], Th becomes activated and
secretes interleukins that activate other cells of
the immune response (NK, mast cells, T cyto-
toxic lymphocytes...).
(b) If one Cell is a T lymphocyte [cytotoxic] (Tc)
and the other Cell is a cancer cell (or a vaccine cell,
a characteristic cell of the CMM-Ontology), the T
cell (identified as CD8+) becomes, in presence of
IL2, an activated T cytotoxic lymphocyte that kills
the other cell (cancer cell or vaccine cell). At the
molecular level, the T cell receptor (TR) at the sur-
face of a naive T lymphocyte [cytotoxic] (Tc) binds
specifically pMHC-I at the surface of the cell (cancer
cell or vaccine cell), in the presence of IL2, T lym-
phocyte [cytotoxic] (Tc) is activated and kills the
other cell (cancer cell or vaccine cell). The two cor-
responding instances of the Cell_Cell_Interaction
concept are:
Figure 3 Concepts of interactions in CMM-Ontology. These concepts have been added to IMGT-ONTOLOGY [6] for defining interactions
between molecules (Molecule_Molecule_Interaction), cells (Cell_Cell_Interaction) and between molecules and cells (Molecule_Cell_Interaction,
Cell_Molecule_Interaction). Main instances of these concepts used in the CMM model are indicated: Immunoglobulin_Antigen (IG_Ag), B
lymphocyte_Antigen (B_Ag), Macrophage_Antigen (M_Ag), Dendritic cell_Antigen (DC_Ag), T lymphocyte [helper]_B lymphocyte (Th_B), T
lymphocyte [helper]_Macrophage (Th_M), T lymphocyte [helper]_Dendritic cell (Th_DC), T lymphocyte [cytotoxic]_Cancer cell (Tc_CC), T
lymphocyte [cytotoxic]_Vaccine cell (Tc_VC), Immunoglobulin_Vaccine cell (IG_VC) and Immunoglobulin_Cancer cell (IG_CC).
Figure 4 Immunoglobulin_Antigen as an instance of the
“Molecule_Molecule_Interaction” concept. This instance is shown
as IG_Ag in Fig. 2. In CMM, Ag is represented by p185.
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• T lymphocyte [cytotoxic]_Cancer cell (Figure 7A).
• T lymphocyte [cytotoxic]_Vaccine cell (Figure 7B).
4. The “Molecule_Cell_Interaction” concept. If the
Molecule is a specific soluble immunoglobulin (IG) and
the Cell is a cancer cell (or a vaccine cell) that expresses
the antigen at its cell surface (in CMM, p185), the solu-
ble IG recognizes specifically the antigen (Figure 8). The
opsonized cell (cell with bound IG on its surface) may
be killed by complement dependent cytotoxicity (CDC)
or by antibody dependent cell cytotoxicity (ADCC). At
the molecular level, the first interaction is the recogni-
tion by the IG of the antigen expressed at the surface of
the cancer cell or vaccine cell. The two corresponding




The consequence of the “Molecule_Cell_Interaction”
in these two instances, that results in the killing (by
CDC or ADCC) of the opsonized cancer cell or vaccine
cell involves new instances of concepts defined above:
• “Molecule_Cell_Interaction”, for CDC (with the
instance Complement_Opsonized cell), or
• “Cell_Cell_Interaction”, for ADCC (with the
instance Natural killer_Opsonized cell).
Figure 5 B lymphocyte_Antigen as an instance of the
“Cell_Molecule_Interaction” concept. This instance is shown as
B_Ag in Fig. 2. In CMM, Ag is represented by p185. Note that the
interaction between the membrane IG, on the surface of the B
lymphocyte, and the antigen is also an instance of the
“Molecule_Molecule_Interaction”. This example illustrates (as the
following figures) how the IMGT-ONTOLOGY concepts of
interactions allow to bridge the gap between the cell and molecule
levels.
Figure 6 T lymphocyte [helper]_B lymphocyte [APC] as an instance of the “Cell_Cell_Interaction” concept. This instance is shown as
Th_B in Fig. 2. Note that the interaction between the T cell receptor (TR), on the surface of the T lymphocyte [helper], and the pMHC-II, on the
surface of the B lymphocyte (as antigen presenting cell or [APC]), is also an instance of the “Molecule_Molecule_Interaction”. This example
illustrates, as Fig. 4, how the IMGT-ONTOLOGY concepts of interactions allow to bridge the gap between the cell and molecule levels.
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Figure 7 T lymphocyte [cytotoxic]_Cancer cell (7A) and T lymphocyte [cytotoxic]_Vaccine cell (7B) as instances of the
“Cell_Cell_Interaction” concept in models related to immunotherapy, as defined in CMM. These instance are shown as Tc CC and Tc VC
in Fig. 2. The interaction between the T cell receptor (TR), on the surface of the T lymphocyte [cytotoxic], and the pMHC-I, on the surface of the
cancer cell or vaccine cell, is also an instance of the “Molecule_Molecule_Interaction”. It represents an additional example of interactions that
bridges the gap between cell and molecule levels in the adaptive immune response (IMGT Education, http://www.imgt.org) [10].
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In CDC, complement (C1q) binds to the Fc of IG at
the surface of the opsonized cell (cancer cell or vaccine
cell), the complement cascade is activated, the mem-
brane attack complex (MAC) is formed in the cell mem-
brane and the cell is killed. In ADCC, Fc receptor
gamma of natural killer cell (NK) binds to the Fc of IG
at the surface of the opsonized cell (cancer cell or vac-
cine cell), NK kills the cell (cancer cell or vaccine cell).
Discussion
An interaction described at the “Cell_Cell_Interaction”
level focuses on the activity, activation status, function,
differentiation status and/or life status of the cells that
interact. If needed, the “Cell_Cell_Interaction” can also
be identified at the “Molecule_Cell_Interaction”, or
“Cell_Molecule_Interaction”, or “Molecule_Molecule_In-
teraction” levels. The level of granularity will depend on
the model and on the kind of data that are available for
the modeling. The four types of interactions can be
used to identify, not only a given interaction, but also a
complex succession of interactions, as described above
for the killing by CDC or ADCC. Finally we have shown
that these concepts of interactions identified in CMM-
Ontology are general for the immune response and, for
that reason, they have been added to IMGT-ONTOLOGY
Figure 8 Immunoglobulin_Cancer cell as an instance of the “Molecule_Cell_Interaction” concept in models related to immunotherapy,
as defined in CMM. This instance is shown as IG_CC in Fig. 2. The interaction between the immunoglobulin and the antigen (Ag), on the
surface of the cancer cell (in CMM, Ag is represented by p185), is the starting event that leads to effector interactions: (i) binding, at the cell
level, of natural killer (NK) to cancer cell ("Cell_Cell_Interaction”) and, at the molecule level, of the Fc receptor (FcR), on the surface of NK, to the
IG that has recognized Ag on the cancer cell surface ("Molecule_Molecule_Interaction”) and (ii) binding of the complement (Cpt) to the IG that
has recognized Ag on the cancer cell surface ("Molecule_Molecule_Interaction”). These interactions by NK or complement lead to the killing of
the cancer cell by ‘antibody dependent cell cytotoxicity’ or ADCC or ‘complement dependent cytotoxicity’ (CDC), respectively (IMGT Education >
IMGT Lexique, ADCC and CDC, http://www.imgt.org).
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[6], the reference in immunogenetics and immunoinfor-
matics. This effort represents, as far we know, the first
attempt at linking the well established molecular ontol-
ogy with cellular ontology in cancer immunology. With
the increasing use of models in biology and medicine
the need of linking different levels, from molecules to
cells to tissues and organs, is increasingly important. As
a matter of fact only a unified ontology framework will
allow to link models at different scales.
Attempts in that direction are, at the moment, based
on the use of markup languages [15-17], i.e. XML, but a
general framework is still to come. In modeling other
pathologies [19-21] we experienced that using an ontol-
ogy driven approach, itself generated from a model,
resulted in speeding up the process of model construc-
tion as well as clarifying the biologist needs regarding
model definion. We believe that this is a powerful
methodology.
A model is a formal description of biological knowl-
edge and its quantitative formulation using mathemati-
cal or computational tools. An ontology based
description of these tools would clarify to biologists the
value of the model results. However very few attempts
in these directions have been made for modeling in phy-
sics and engineering [22]. We expect that the increasing
interest in mathematical modeling in life science will
push toward an increasing interest in this aspect in a
near future.
Conclusion
In this paper we presented a first attempt, generated
from a model, at defining an integrated molecular -cel-
lular ontology to be used in modeling biological pro-
blems. As the overall goal of this approach is to use a
standardized approach to describe biological entities we
plan to adapt in the future this methodology to the
most widely used software tool in this field, i.e. Protégé
http://protege.stanford.edu). Work in this direction is in
progress and results will be published in due course.
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